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The large subunit of herpes simplex virus (HSV) ribonucleotide reductase (RR1) designated ICP6 and ICP10 for HSV-1
and HSV-2, respectively, has a novel protein kinase (PK) enzymatic activity. ICP10 is localized on the cell surface, a
localization that depends on an intact transmembrane (TM) segment. We used immunocomplex PK assays to examine the
PK activity of ICP10 in stably transfected eukaryotic cells. Activity was distinct from that of casein kinase II (CKII) in that it
did not require monovalent ions and was not inhibited by zinc sulfate. PK activity was eliminated by deletion of the conserved
PK catalytic motifs or of the TM segment and it was significantly impaired by mutation of the invariant Lys (Lys176). Loss
of PK activity by Lys176 mutation resulted in the failure to bind ATP. A truncated ICP10 PK expressed in bacteria (pp291a1)
retained auto- and transphosphorylating activity (for calmodulin) after purification to apparent homogeneity. PK activity was
also absent in cells infected with a recombinant virus (ICP10DPK) deleted in the ICP10 PK catalytic motifs. In cells infected
with HSV-1 or HSV-2, RR1 had auto- and transphosphorylating activity for the small subunit of HSV ribonucleotide reductase
(RR2) and immunoglobulin G (IgG). Comparing the PK activity of ICP6 and ICP10 we found that ICP6 requires five-fold higher
concentrations of [g-32P]ATP than ICP10 and both enzymes are Mn2/ dependent, which is also different from CKII that is
primarily Mg 2/-dependent. Similar results were obtained for various HSV strains and in different cell lines. The data are
consistent with the conclusion that the RR1 PK activity is intrinsic. q 1996 Academic Press, Inc.
INTRODUCTION and Aurelian, 1978; Middleton et al., 1982; Hayward,
1986; Kwong and Frenkel, 1987). It has a bipartite regula-
Ribonucleotide reductase (RR) plays a pivotal role in
tion including activation by ICP0, like all other DE genes,eukaryotic and prokaryotic cell DNA synthesis. Herpes
and by the virion protein VP16, like all other IE genessimplex virus (HSV) expresses a distinct RR that, like
(Wymer et al., 1989, 1992; Sze and Herman, 1992; Desaithe cellular enzyme, consists of two heterologous pro-
et al., 1993; Ramakrishnan et al., 1994). It has been sug-tein subunits. The small subunit (RR2) is a 38-kDa pro-
gested that the IE regulation of the RR1 proteins is re-tein encoded by the HSV gene UL40. The large subunit
quired for the unique protein kinase (PK) activity which(RR1), designated ICP6 and ICP10 for HSV types 1 and
is localized at the amino-terminus of the molecule (Chung2, respectively, is a 140-kDa protein encoded by the
et al., 1989, 1990; Luo et al., 1991; Paradis et al., 1991;UL39 gene (Langelier and Buttin, 1981; Anderson et
Ali et al., 1991, 1992; Luo and Aurelian, 1992; Conner etal., 1981; Dutia, 1983; McLauchlan and Clements, 1983;
al., 1992a; Cooper et al., 1995) and functions indepen-Averett et al., 1983; Bacchetti et al., 1984, 1986; Frame
dently of the RR activity (Ingermason and Lankinen, 1987;et al., 1985; Cohen et al., 1985; Ingemarson and Lanki-
Lankinen et al., 1989; Chung et al., 1989, 1990, 1991;nen, 1987).
Conner et al., 1992b, 1994). HSV-2 DNA sequences thatIt is generally accepted that in addition to their role in
encode the ICP10 amino-terminus cause neoplasticRR activity, the RR1 proteins can function independently
transformation of rodent and human cells (Jariwalla etof RR2 as demonstrated by the different regulation and
al., 1980; Hayashi et al., 1985; Iwasaka et al., 1985; Jari-kinetics of their expression. RR2 is regulated as a de-
walla et al., 1986; Jones et al., 1986; Ali et al., 1991, 1992;layed early (DE) gene the expression of which peaks at
Smith et al., 1992, 1994). Transformation depends on6–8 hr postinfection (p.i.) and is activated by the immedi-
membrane anchorage and PK activity of the protein prod-ate early (IE) protein ICP0. RR1 synthesis is first observed
uct and is associated with activation of the ras signalingat 1–2 hr p.i. and in the presence of cycloheximide
pathway (Smith et al., 1994; Hunter et al., 1995).(Honess and Roizman, 1974; Morse et al., 1978; Strnad
The findings that the PK domain is present only in the
HSV RR1 proteins (Nikas et al., 1986), and it is dispensi-1 To whom reprint requests should be addressed at Biomedical Re-
search Facility, 108 N. Greene Street, Baltimore, MD 21201. ble for ribonucleotide reduction (Ingermason and Lanki-
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nen, 1987; Lankinen et al., 1989; Conner et al., 1992b), line 4-JN10 that constitutively expresses pJHL4 was es-
tablished in transfected 293 cells by G418 selectionsuggest that the PK activity plays a significant role in
virus pathogenesis. Presumably this involves the ability (Smith et al., 1994).
of RR1 PK to transphosphorylate viral IE and/or cellular
Virusesproteins that regulate virus gene expression (Wymer et
al., 1989; Desai et al., 1993; Ramakrishnan et al., 1994; HSV-1 (MP) and HSV-2 (G) were described (Ejercito et
Conner et al., 1994). A wealth of evidence indicates that al., 1968). Fresh virus isolates typed as HSV-1 (Sco1,
the RR1 PK activity is intrinsic (Chung et al., 1989, 1990; Sco2, Sco3) or HSV-2 (LF, SB) by immunofluorescent
Luo et al., 1991; Paradis et al., 1991; Ali et al., 1991, 1992; staining with specific antibodies (Electronucleonics)
Luo and Aurelian, 1992; Conner et al., 1992a; Cooper were obtained from the UMAB clinical virology labora-
et al., 1995). However, conflicting results were obtained tories. The strategy used to construct ICP10DPK virus is
relative to its transphosphorylating ability (Chung et al., shown in Fig. 1. The wild-type sequences in a plasmid
1989; Paradis et al., 1991; Conner et al., 1992a; Cooper (TP101) that contains the HSV-2 DNA BamHI E and T
et al., 1995; Ali, 1995), and more recently the intrinsic fragments were replaced with the 1.8-kb Sal I/Bgl II frag-
nature of the PK activity was brought into question (Y. ment from pJHL9 [ICP10 mutant deleted in the PK cata-
Langelier, personal communication). Here we report the lytic domain (Luo and Aurelian, 1992), Fig. 2A]. The re-
results of our studies designed to ask the question sulting plasmid, TP9, contains sequences which code for
whether ICP10 PK activity is intrinsic, and directly com- ICP10 deleted in the PK catalytic domain flanked by 4
pare the ICP10 and ICP6 PK activities in virus-infected and 2.8 kb of HSV-2 DNA sequences at the 5* and 3*
cells under various experimental conditions. ends, respectively. The 10-kb HindIII/EcoRI fragment
from TP9 was introduced by marker transfer into a virus
MATERIALS AND METHODS (ICP10DRR) that gives rise to blue plaques upon staining
with X-gal because the RR domain of ICP10 had beenPlasmids
replaced with the LacZ gene (Peng et al., in preparation).
The resulting recombinant virus, designated ICP10DPK,Bacterial expression vector pJL11 was obtained from
gives rise to white plaques. A few white plaques wereDr. J. H. Luo (Columbia University). Its construction and
picked, purified, and grown in Vero cells with 10% serumproperties were described (Luo et al., 1991). JL11 con-
(exponentially growing).tains ICP10 PK fused to the 5* portion of the lambda
phage N protein. Upon induction it expresses a 29-kDa
Antibodiesprotein (ICP10 amino acids 1–283) designated pp291a1.
Eukaryotic expression vector pJHL4 in which Lys176 was The following monoclonal antibodies (MAbs) were pre-
mutated to Leu (Luo and Aurelian, 1992) was obtained viously described (Chung et al., 1989, 1991; Luo et al.,
from Dr. L. Aurelian (University of Maryland, Baltimore). 1991): MAb99 specific for HSV-2 RR2, and MAbs 30, G8,
A 30% ammonium sulfate fraction of induced bacteria and G9 that are specific for RR1. MAb30 is HSV-2 spe-
was prepared and further purified by heparin chromatog- cific. MAbs G8 and G9 are HSV-type common. The epi-
raphy as described (Furlong et al., 1991; Conner et al., topes are located within amino acid residues 1–100,
1992b). 180–283, and 200–283 for MAb30, G8, and G9, respec-
tively. The production and specificity of the anti-LA-1 anti-
Cells body for ICP10 amino acids 13–26 were described (Aure-
lian et al., 1989).African Green monkey (Vero) and Human epidermoid
carcinoma No. 2 (HEp-2) cells were obtained from Ameri-
Labeling of cell extracts and immunoprecipitation
can Type culture collection and grown in minimal essen-
tial medium (MEM) supplemented with 10% fetal calf se- Vero cells were infected with HSV-1 or HSV-2 [20
plaque forming units (PFU)/cell] and incubated in methio-rum (FCS). Syrian hamster embryo cells immortalized
with the EcoRI/HindIII AE fragment of HSV-2(333) DNA nine-free MEM supplemented with 10% dialyzed FCS.
They were labeled with [35S]methionine (100 mCi/ml, sp(AE cells) were obtained from Dr. P. O. P. Ts’o (Johns
Hopkins University, Baltimore, MD). They were grown in act 1120 Ci/mmol, NEN Research Products, Boston, MA)
at 2–10 hr postinfection (p.i.). In some experiments, infec-Dulbecco’s modified Eagle’s medium with 10% FCS.
Lines JHLa1, JHL15, and JH9 that, respectively, express tion was done in the presence of cycloheximide (50 mg/
ml) for 6 hr at which time cycloheximide was removedICP10, a TM deleted ICP10 mutant (pJHL15), or an ICP10
mutant deleted in the conserved PK catalytic motifs and the cells were incubated (1 hr) in the presence of
[35S]methionine. Cell lysates were prepared at these(pJH9) were obtained from Dr. C. C. Smith (University of
Maryland, Baltimore) and grown as described (Smith et times in RIPA buffer [150 mM NaCl, 20 mM Tris–HCl,
pH 7.4, 0.1% sodium dodecyl sulfate (SDS), 1% Nonidetal., 1994; Hunter et al., 1995). pJHL9 expresses a PK-
negative 95-kDa protein (Luo and Aurelian, 1992). Cell P-40 (NP-40), 1% sodium deoxycholate, 1 mM phenyl-
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FIG. 1. Schematic representation of the strategy used to construct ICP10DPK virus. The 1.8-kb Sal I/Bgl II fragment from pJHL9 was introduced
into TP101 replacing the wild-type sequences. The resulting plasmid (TP9) contains sequences that encode ICP10 deleted in the conserved
PK catalytic motifs (p95) flanked by HSV-2 DNA sequences. Marker transfer of the HindIII/EcoRI fragment from TP9 into infectious blue plaque
virus ICP10DRR (ICP10 RR domain replaced with the LacZ gene) was used to generate the recombinant virus ICP10DPK.
methylsulfonyl fluoride (PMSF) (Sigma Chemical Co., St. buffer containing 150 mM NaCl, 20 mM Tris – HCl (pH
7.4), and suspended in 50 ml of kinase reaction bufferLouis, MO), 100 Kallikrein units/ml aprotinin (Sigma)] and
(20 mM Tris – HCl, pH 7.4; 5 mM MgCl2 and 2 mMcleared of cell debris by centrifugation at 20,000g for 30
MnCl2). The kinase reaction was terminated by boilingmin. They were incubated with 15 ml of antibody (1 hr,
in 100 ml of 0.5% denaturing solution and the proteins47C) and 100 ml of protein A-Sepharose CL4B beads (50%
were resolved by SDS – PAGE. To control for the quan-v/v, Sigma) (30 min 47C). Beads were extensively washed
tity of RR1 in the PK assays, proteins were transferredin ice-cold RIPA buffer and bound proteins were eluted
to nitrocellulose membranes and immunoblotted withby boiling (5 min) in 50 ml denaturing solution [150 mM
the respective antibodies followed by protein A-peroxi-Tris–HCl (pH 7.0), 5.7% SDS, 14% 2-b-mercaptoethanol,
dase (Sigma) for 1 hr at room temperature each. Detec-17% sucrose, 0.04% bromthymol blue]. Proteins were re-
tion was with ECL reagents (Amersham, Arlingtonsolved by SDS–PAGE on 8.5% polyacrylamide gels and
Heights, IL) and quantitation was by densitometricvisualized by autoradiography. Quantitation was by den-
scanning (Smith et al., 1994). Assays were done with 1sitometric scanning using the NIH Image program ver-
mg protein, a concentration at which signaling proteinssion 1.44 and results are expressed as densitometric
that bind ICP10 are not detected (Smith et al., 1994).integration units.
In some experiments, the PK assays were done in reac-
tion buffer containing 150 mM KCl which is requiredImmunocomplex PK assay/immunoblotting
for optimal CKII activity (Gatica et al., 1993) or 50 – 400
Immunoprecipitates of infected cell extracts normal- mM zinc sulfate which inhibits CKII activity (Gatica et
al., 1993).ized for protein concentration were washed with a
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Binding of [14C]fluorosulfonylbenzoyl 5*-adenosine
(FSBA)
MAb30 immunoprecipitates were incubated in sepa-
rate reactions with [14C]FSBA (50 mCi/mol; DuPont New
England Nuclear) as described (Luo and Aurelian, 1992).
The reaction was initiated by adding 3 mCi of [14C]FSBA
in 5% dimethyl sulfoxide, 10 mM MgCl2 , 10 mM HEPES
(pH 7.5) to the precipitates. Similar reactions were done
in the presence of 1 mM AMP-PNP (Boehringer Mann-
heim). The precipitates were incubated 30 min at 307C,
washed with Tris-saline buffer (pH 7.4) and the proteins
were resolved by SDS–PAGE on 7% polyacrylamide gels.
RESULTS
Deletion and site-directed ICP10 mutants with
impaired PK activity
ICP10 mutants deleted in the conserved PK catalytic
motifs (pJHL9, amino acids 106–445) or the TM segment
(pJHL15, amino acids 86 –105) (Fig. 2A) were shown to
be PK negative in transiently or stably transfected cells
(Luo and Aurelian, 1992; Smith et al., 1994; Hunter et al.,
1995). A site-directed mutant (pJHL4) in Lys176 had 2- to
2.5-fold lower PK activity than the wild-type ICP10 (Luo
and Aurelian, 1992), but the assay was done on tran-
siently transfected cells in which expression is notori-
ously difficult to control and the protein levels in the
mutant and wild-type PK assays were not equilibrated.
We established a pJHL4 stably transfected cell line (4-
FIG. 2. (A) Schematic representation of ICP10 and mutants pJHL15JN10) and used it in immunocomplex PK assays with
(TM deleted), pJHL9 (deleted in PK catalytic motifs), and pJHL4 (site-MAb30 to examine the levels of kinase activity relative to
directed in Lys176). (B) MAb30 immunocomplex PK assay of extracts
those in ICP10 expressing cells (JHLa1). Cells expressing from JHLa1 (lane 1), 4-JN10 (lane 2), JHL15 (lane 3), and JHL9 (lane 4)
JHL15 (TM deleted mutant) or JHL9 [expresses 95-kDa cells. The assay was done with 10 mCi of [g-32P]ATP and 2 mM Mn2//
protein deleted in the PK catalytic domain (Luo and Aure- 5 mM Mg 2/. (C) Immunoblotting of the PK immunoprecipitates in B
with anti-LA-1 antibody.lian, 1992)] (Fig. 2A) were studied in parallel. Proteins
from the SDS–PAGE of the PK immunoprecipitates were
transferred to nitrocellulose membranes and immu-
sonal communication). Notwithstanding, we sought tonoblotted with anti-LA-1 antibody to control for the ICP10
further evaluate the contribution of CKII by examining thequantity in the PK assays. Phosphorylated ICP10 was
effect of zinc sulfate and monovalent cations on ICP10observed in PK assays of JHLa1 cells (Fig. 2B, lane 1).
PK activity. CKII activity requires monovalent cations andIts levels were 5- to 6-fold lower in 4-JN10 cells (Fig. 2B,
it is inhibited by ZnSO4 , being totally ablated at 200–400lane 2) and the protein was not seen in JHL15 (Fig. 2B,
mM (Gatica et al., 1993). On the other hand, ICP10 kinaselane 3) or JHL9 (Fig. 2B, lane 4) cells. The decrease/loss
activity was identical in the absence or presence of KClof PK activity is specific, since virtually identical levels
and it was not inhibited by ZnSO4 , even at 400 mM (Fig. 3).of ICP10 protein were seen in PK-positive and -negative
Immunoblotting of the MAb30 immunoprecipitates withprecipitates by immunoblotting with anti-LA-1 antibody
antibody to CKII (UBI, Lake Placid, NY) was also negative(Fig. 2C). These findings indicate that ICP10 PK activity
(data not shown). These data indicate that ICP10 PK ac-is intrinsic.
tivity is unrelated to CKII.
ICP10 PK activity is unrelated to CKII
Effect of ICP10 mutation on [14C]FSBA binding
Computer based analysis (GCG/Wisconsin V8.0 MO-
TIFS program) indicates that JHL15 and JHL4 retain all The observation that the ICP10 PK activity is signifi-
cantly (5- to 6-fold) reduced by mutation of Lys176 sug-known target sites for cellular PKs, including those for
CKII which has recently been suggested as the contami- gests that this residue is involved in catalysis, substrate
recognition, or structural integrity of the catalytic site. Tonant responsible for ICP10 PK activity (Langelier, per-
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FIG. 3. Effect of KCl and zinc sulfate on ICP10 PK activity. Immuno-
FIG. 5. Immunocomplex PK assay of extracts from JHL15 (lanes 1,complex PK assays were done on extracts of JHLa1 cells with MAb30
3, 5, 7) or JHLa1 (lanes 2, 4, 6, 8) cells with MAb30 (lanes 1, 2), MAbG8in the absence or presence of 150 mM KCl or 50–400 mM zinc sulfate.
(lanes 3, 4), MAbG9 (lanes 5, 6), or NMS (lanes 7, 8). The assay wasResults are expressed as percentage of kinase activity relative to
done with 10 mCi of [g-32P]ATP and 2 mM Mn2//5 mM Mg 2/.assays done without KCl or ZnSO4 and quantitated by densitometric
scanning.
1–413) as suggested by Luo and Aurelian (1992) and as
further examine the role of Lys176 in ICP10 PK activity, shown for yeast cAMP kinase by Gibbs and Zoller (1991).
JHLa1 and 4-JN10 cell extracts were immunoprecipitated
with MAb30 and the precipitates were incubated with ICP10 PK activity is not due to contaminating kinases
the 14C-labeled ATP analogue FSBA, in the presence or in the MAb used in the assay
absence of the nonhydrolyzable ATP analogue AMP-
To examine whether the ICP10 PK activity is due toPNP, used as competitor. JHL9 cells that express a 95-
contamination by kinases present in the MAb used for PKkDa ICP10 mutant deleted in the conserved PK catalytic
assays, extracts of JHLa1 and JHL15 cells were studied inmotifs (Fig. 2A) served as additional control. [14C]FSBA
immunocomplex PK assays with MAbs 30, G8, and G9.bound ICP10 (Fig. 4, lane 1) and binding was competed
Phosphorylated ICP10 was recognized by all three MAbsby AMP-PNP (Fig. 4, lane 3). Deletion of the ICP10 PK
in JHLa1 (Fig. 5, lanes 2, 4, 6) but not in JHL15 (Fig. 5,catalytic motif abrogated FSBA binding (Fig. 4, lane 5)
lanes 1, 3, 5) cells. Additional phosphorylated proteinsconfirming that the ATP binding site is located within
were not seen in MAb30 precipitates from JHLa1 orthe PK catalytic domain at positions 1–413. Binding was
JHL15 cells (Fig. 5, lanes 1, 2). However, a phosphory-reduced (5-fold) by mutation of Lys176 (Fig. 4, lane 2) and
lated protein consistent with IgG was seen in MAbG8it was competed by AMP-PNP (Fig. 4, lane 4). These
precipitates from JHLa1 (Fig. 5, lane 4), but not JHL15findings indicate that ATP binds Lys176 as well as another
(Fig. 5, lane 3) cells, and three phosphorylated proteinsLys residue within the PK catalytic domain (amino acids
other than ICP10 were seen in MAbG9 precipitates from
both JHLa1 (Fig. 5, lane 6) and JHL15 (Fig. 5, lane 5) cells.
Similar results were obtained with purified IgG (data not
shown). These findings suggest that ICP10 kinase activ-
ity is not due to a contaminating kinase present in the
antibodies. However, the MAb specificity might be re-
sponsible for the present conflict about RR1 transphos-
phorylating activity (Conner et al., 1992; Ali, 1995) as evi-
denced by the observation that MAbG9 coprecipitates
three unidentified phosphorylated proteins from both
JHLa1 and JHL15 cells.
ICP10DPK virus does not have ICP10 PK activity
We considered the possibility that in virus-infected
FIG. 4. Binding of [14C]FSBA to ICP10. Immunoprecipitates of JHLa1
cells ICP10 is phosphorylated by another viral kinase or(lanes 1, 3), 4-JN10 (lanes 2, 4), or JHL9 (lanes 5, 6) cells were incubated
by cellular kinases induced by virus infection. Havingwith [14C]FSBA in the absence (lanes 1, 2, 5) or presence (lanes 3, 4,
6) of 1 mM AMP-PNP. shown that ICP10 PK activity is intrinsic in stably
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MAbG8 and 10, or 50 mCi of [g-32P]ATP. The reaction
buffer contained 2 mM Mn2//10 mM Mg 2/ and normal
mouse serum (NMS) served as control. Immunoblotting
of the PK immunocomplexes with MAbG8 was used to
establish the levels of RR1 protein in the precipitates.
ICP10 (Fig. 7A, lane 1) and ICP6 (Fig. 7A, lane 2) were
precipitated by MAbG8 from [35S]methionine-labeled
HSV-2- and HSV-1-infected cells, respectively. The levels
of the precipitated ICP10 and ICP6 were similar (densito-
metric integration units  24,733 { 1,532 and 24,725 {
2,006 for ICP10 and ICP6, respectively), indicating that
the proteins are expressed equally well in HSV-2- and
HSV-1-infected Vero cells. As previously reported (Chung
FIG. 6. (A) MAb30 immunocomplex PK assay of extracts from cells et al., 1989, 1991), a 38-kDa protein that probably repre-infected (10 hr p.i.) with ICP10DPK (lane 1) or HSV-2 (lane 2). (B)
sents RR2 coprecipitates with RR1 from 10 hr-infectedImmunoblotting of the PK precipitates in A with anti-LA-1 antibody.
cells (Fig. 7A, lanes 1, 2). The proteins were not precipi-Molecular weight markers are shown.
tated by NMS (Fig. 7A, lane 4) nor by MAbG8 from simi-
larly labeled mock-infected Vero cells (Fig. 7A, lane 3).
transfected cells, and that pJHL9 does not have PK activ- Phosphorylated RR1 was detected in the MAbG8 im-
ity and does not bind FSBA, we used this plasmid to munocomplex PK assays of HSV-2-infected cell extracts
construct the recombinant virus ICP10DPK (Fig. 1). Expo- done with 10 (Fig. 7B, lane 1) or 50 (Fig. 7B, lane 2) mCi
nentially growing HEp-2 cells were infected with HSV-2 of [g-32P]ATP and their levels were similar (densitometric
or ICP10DPK virus (m.o.i.  20) and cell extracts ob- integration units  56,641 { 1,455 and 66,890 { 1,987
tained at 10 hr p.i. were assayed in immunocomplex PK for 10 and 50 mCi [g-32P]ATP, respectively). By contrast
assays with MAb30. Proteins were transferred to nitrocel- the phosphorylated RR1 protein was not observed in
lulose membranes and immunoblotted with anti-LA-1 an- MAbG8 immunocomplex PK assays of HSV-1-infected
tibody. Phosphorylated ICP10 and a 38-kDa protein con-
sistent with RR2 were observed in HSV-2 infected cells
(Fig. 6A, lane 2) but there were no phosphorylated pro-
teins in ICP10DPK-infected cells (Fig. 6A, lane 1). Loss
of PK activity is due to deletion of the ICP10 PK catalytic
motifs since immunoblotting with anti-LA-1 antibody
identified ICP10 and the PK-deleted 95-kDa protein in
HSV-2 (Fig. 6B, lane 2) and ICP10DPK (Fig. 6B, lane 1)
infected cells, respectively. These data indicate that the
ICP10 PK activity is intrinsic, also in virus-infected cells.
ATP requirements for ICP10/ICP6
autophosphorylation in virus-infected cells
Cooper et al., (1995) concluded that ICP6 PK activity
is intrinsic and the ATP-binding site is at position 305–
575, distant from the rest of the PK catalytic motifs. This
is consistent with the observation that the Lys residue
in PK catalytic motif II (Lys176 in ICP10) is not conserved
in ICP6 (Chung et al., 1989). It is different, however, from
FIG. 7. ICP10 and ICP6 PK activity in virus-infected cells. (A) Immuno-our findings for ICP10 which limit the ATP binding site
precipitation of [35S]methionine-labeled Vero cells infected with HSV-to amino acids 106–411 and indicate that Lys176 is at
2(G) (lane 1), HSV-1 (MP) (lanes 2, 4), or mock-infected (lane 3) for 10least one of the residues that bind ATP. Accordingly, the
hr with MAbG8 (lanes 1–3) or NMS (lane 4). (B) MAbG8 immunocom-
two PK activities may differ, at least in terms of their ATP plex PK assay of 10 hr HSV-2-infected (lanes 1, 2) or mock-infected
requirements. To address this question, Vero cells were (lane 3) Vero cells at 10 (lane 1) or 50 (lanes 2, 3) mCi of [g-32P]ATP.
(C) MAbG8 immunocomplex PK assay of 10 hr HSV-1-infected Veroinfected with 20 PFU/cell of HSV-1 (MP) or HSV-2 (G) or
cells with MAbG8 at 10 (lane 1) or 50 (lane 2) mCi of [g-32P]ATP or withmock-infected with phosphate-buffered saline (pH 7.0)
NMS at 50 mCi of [g-32P]ATP (lane 3). (D) Immunoblotting with Protein(PBS) for 10 hr, labeled with [35S]methionine (100 mCi)
A peroxidase of gels from HSV-2 (lane 1) or HSV-1 (lanes 2, 3) infected
beginning at 2 hr p.i. and immunoprecipitated with cells shown in B, lane 1, and C, lanes 1 and 2, respectively. (E) Immu-
MAbG8. Duplicate unlabeled cultures were harvested at noblotting with MAbG8 of PK immunocomplexes shown in B and C.
Molecular weight markers are shown.10 hr p.i. and assayed in immunocomplex PK assays with
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cell extracts assayed with 10 mCi of [g-32P]ATP (Fig. 7C,
lane 1; densitometric integration units 2,386 { 1,773) or
25 mCi of [g-32P]ATP (data not shown). The phosphory-
lated RR1 was seen in MAbG8 immunocomplex PK
assays of HSV-1-infected cell extracts in the presence
of 50 mCi of [g32P]ATP (Fig. 7C, lane 2) but its levels
(densitometric integration units  21,313 { 1,877) were
significantly lower than those of the phosphorylated
ICP10 detected under similar assay conditions. In a reac-
tion mixture consisting of 0.1 mM [g-32P]ATP (10 mCi)
and 0.4 mM cold ATP phosphorylated ICP6 was barely
detectable (data not shown), indicating that 10 mCi is
the minimal amount of [g-32P]ATP that is needed for a
detectable reaction. Phosphorylated RR1 was not ob-
FIG. 8. (A) PK activity of 10 hr mock-infected (lane 1) or HSV-2-
served in MAbG8 immunocomplex PK assays of mock- infected (lanes 2, 4, 5) Vero cells or of Vero cells infected with HSV-2
infected Vero cells (Fig. 7B, lane 3) nor in virus-infected in the presence of cycloheximide (lane 3) with MAb99 (lanes 1, 2),
MAbG8 (lane 3), or NMS (lanes 4, 5). (B) MAbG8 immunoprecipitationcells assayed with NMS and 50 mCi of [g-32P]ATP (Fig.
of 10-hr extracts from [35S]methionine-labeled Vero cells infected with7C, lane 3). Comparison of the ICP10 and ICP6 PK activi-
Sco1 (lane 1), Sco2 (lane 2), or LF (lane 3) viruses. (C) MAbG8 immuno-ties is valid since immunoblotting of the PK immunocom-
complex PK assays of cells in B with 50 (lanes 1–3) or 10 (lanes 4–
plexes indicated that they contain virtually identical levels 6) mCi of [g-32P]ATP. Molecular weight markers and proteins identity
of RR1 protein (Fig. 7E). These observations indicate that are shown.
the PK activity of ICP6 requires significantly higher (5-
fold) levels of ATP than that of ICP10.
4,604{ 1,001) or with NMS (Fig. 7C, lane 3; densitometric
integration units  3,421 { 963). These observations
ATP requirements for ICP10/ICP6 suggest that the 38- and 55-kDa proteins are phosphory-
transphosphorylating activity in virus-infected cells lation substrates for ICP10/ICP6. The 55-kDa protein is
also phosphorylated in uninfected cells (by cellular PKs)Two phosphorylated proteins 55 and 38 kDa, respec-
but its levels are significantly higher in virus-infectedtively, were seen in immunocomplex PK assays with
cells, suggesting that it is also a substrate for RR1 PK.MAbG8 and extracts from HSV-2- or HSV-1-infected cells.
The observation that the levels of phosphorylated 55 kDaThey were seen in HSV-2-infected cells assayed with 10
in HSV-1-infected cells assayed with 10 mCi of [g-32P]ATPor 50 mCi of [g-32P]ATP (Fig. 7B, lanes 1, 2) and their
are similar to those seen in mock-infected cells assayedlevels were similar at both ATP concentrations (densito-
with a 5-fold higher ATP concentration, giving added sup-metric integration units  88,895 { 11,542 and 57,130
port to the conclusion that the protein is a substrate for{ 2988; 22,834 { 1218 and 14,816 { 1321 for 55 kDa
ICP6 PK activity.and 38 kDa at 50 and 10 mCi of [g-32P]ATP, respectively).
The 38-kDa protein was not seen in MAbG8 immunopre-
RR2 and IgG are transphosphorylation
cipitates from mock-infected cells (Fig. 7B, lane 3) nor in
substrates of ICP6/ICP10
assays done with NMS instead of MAbG8 (Fig. 7C, lane
3). It was also not seen in MAbG8 immunoprecipitates To identify the 55-kDa protein, the gels from the
MAbG8 immunocomplex PK assays from HSV-2-infectedfrom cells infected with HSV-2 in the presence of cyclo-
heximide (Fig. 8A, lane 3), conditions that support the cells (Fig. 7B, lane 2) or HSV-1-infected cells (Fig. 7C,
lanes 1, 2) were immunoblotted with Protein A peroxi-expression of RR1 but not RR2 (Strnad and Aurelian,
1978; Wymer et al., 1989). In HSV-1-infected cells, the 38- dase. The 55-kDa protein was recognized by Protein A
(Fig. 7D), suggesting that it is IgG. To identify the 38-kDakDa phosphorylated protein was only seen in MAbG8
assays done with 50 mCi of [g-32P]ATP (Fig. 7C, lane 2). protein, extracts of HSV-2-infected cells were assayed in
immunocomplex PK assays with MAb99 that specificallyThe 38-kDa protein was not seen when the assay was
done with 10 mCi of [g-32P]ATP, a concentration that also recognizes the HSV-2 RR2 (Chung et al., 1991). Two phos-
phorylated proteins 38 and 140 kDa, respectively, werefails to support the ICP6 autophosphorylating activity
(Fig. 7C, lane 1; densitometric integration units  2,386 seen in extracts from HSV-2-infected cells (Fig. 8A, lane
2) but not in extracts from mock-infected cells (Fig. 8A,{ 1,773 and 100 { 95 for ICP6 and 38 kDa, respectively).
The levels of the phosphorylated 55-kDa protein detected lane 1), nor in NMS precipitates (Fig. 8A, lanes 4, 5). The
180-kDa protein detected in the HSV-2-infected cells mayunder these conditions (Fig. 7C, lane 1; densitometric
integration units  8,480 { 3,563) were similar to those represent the cellular protein coprecipitated by MAb99
with the RR1/RR2 complex (Chung et al., 1991). Becauseseen in assays of mock-infected cells with 50 mCi of [g-
32P]ATP (Fig. 7B, lane 3; densitometric integration units we do not possess an antibody that specifically recog-
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nizes the HSV-1 RR2 protein, we could not repeat these
experiments with HSV-1-infected cells. However, the
data suggest that in virus-infected Vero cells, both ICP10
and ICP6 can transphosphorylate IgG and a 38-kDa pro-
tein which appears to be RR2.
Different HSV strains have similar
ICP6/ICP10PK activity
We considered the possibility that HSV isolates may
have intrinsically different PK activity and repeated the
immunocomplex PK assays using extracts of Vero cells
infected with different patient isolates, three of which had
been typed as HSV-1 (Sco1-3) and two as HSV-2 (LF and
SB). All five isolates were studied at passage 3 in culture.
Vero cells were infected with the isolates at 20 PFU/
cell and labeled with [35S]methionine at 2–10 hr p.i. to FIG. 9. ICP10/ICP6 PK activity in different HSV-infected cells. (A)
determine protein expression. Thirty percent ammonium Immunoprecipitation of [35S]methionine-labeled HEp-2 cells infected
with HSV-1 strain MP (lane 1), HSV-2 strain G (lane 2) for 10 hr withsulfate fractions of unlabeled cell duplicates were used
MAbG8. (B) MAbG8 immunocomplex PK assay of 10 hr HSV-2-infectedin immunocomplex PK assays with MAbG8 and 10 or 50
HEp-2 cells at 50 mCi of [g-32P]ATP. (C) MAbG8 immunocomplex PKmCi of [g-32P]ATP. As shown in Fig. 8B, lanes 1, 2, for
assay of 10 hr HSV-1-infected HEp-2 (lanes 1, 3) or AE (lane 2) cells
two HSV-1 isolates (Sco1, Sco2) and in lane 3, for one at 10 (lanes 1, 2) or 50 (lane 3) mCi of [g-32P]ATP.
HSV-2 isolate (LF), RR1 proteins were expressed equally
well by all five viruses and their expression levels were
similar to those seen for the laboratory strains (Fig. 7A). HSV-2 (G)-infected HEp-2 and AE cells. MAbG8 immuno-
Phosphorylated proteins consistent with RR1, IgG, and complex PK assays of 10-hr-infected cells were done as
RR2 were seen for all the isolates in immunocomplex PK described above with 10 and 50 mCi of [g-32P]ATP. As
assays done with 50 mCi of [g-32P]ATP, but their levels shown in Fig. 9A for HSV-1 (lane 1)- and HSV-2 (lane 2)-
were significantly lower for the HSV-1 isolates (Fig. 8C, infected HEp-2 cells, protein expression was similar to
lanes 1, 2; densitometric integration units 3,584–9,754; that seen in Vero cells (Fig. 7A, lanes 1, 2). Phosphory-
5,772–10,833; 18,086–18,601 for ICP6, IgG, and RR2, re- lated RR1, IgG, and RR2 were observed in HEp-2 cells
spectively) than the HSV-2 isolates (Fig. 8C, lane 3; densi- infected with HSV-2 (Fig. 9B, lane 1) or HSV-1 (Fig. 9C,
tometric integration units 48,313–55,121, 39,956–41,319, lane 3) when the assay was with 50 mCi of [g-32P]ATP.
and 24,944–23,982 for ICP10, IgG, and RR2, respectively). The levels of the phosphorylated proteins were similar to
Phosphorylated proteins were not seen in extracts from those seen in infected Vero cells (Fig. 8). Phosphorylated
cells infected with the HSV-1 isolates assayed with only proteins were virtually undetectable in HSV-1-infected
10 mCi of [g-32P]ATP (Fig. 8C, lanes 4, 5) while they were HEp-2 (Fig. 9C, lane 1) or AE (Fig. 9C, lane 2) cells as-
seen in parallel assays of cells infected with the HSV-2 sayed with 10 mCi of [g-32P]ATP, suggesting that the cell
isolates (Fig. 8C, lane 6). These findings indicate that the type does not contribute to the RR1 activity.
requirement by ICP6 PK for higher ATP concentrations
Mg 2/ and Mn2/ requirementsis a general property of HSV-1 strains. The ATP concen-
of ICP10/ICP6 PK activitytrations required by ICP10 from various HSV-2 strains is
at least 5-fold lower.
These experiments examined the effect of Mg 2/ and
Mn2/ ions on ICP10 and ICP6 PK activity. By utilizing aICP6/ICP10 PK activity in various infected cells
checkerboard matrix of differing ion concentrations
(ranging between 0 and 10 mM ), the relative require-Previous studies by Ali and his colleagues indicated
that ICP10 has both auto- and transphosphorylating activ- ments of the ICP6 and ICP10 PKs for Mg 2/ and Mn2/
ions could be evaluated. The data in Fig. 10 representity in Cos-7 and Rat-2 cells transfected with ICP10 eu-
karyotic expression vectors (Ali et al., 1991, 1992). How- the results obtained for HSV-1 (MP)-infected Vero cells
assayed with 50 mCi of [g-32P]ATP; the data in Fig. 11ever, transphosphorylating activity was not observed in
HSV-2- or HSV-1-infected CV-1 cells (Ali, 1995). A possi- represent the results obtained for HSV-2 (G)-infected
Vero cells assayed with 10 mCi of [g-32P]ATP.ble interpretation of these conflicting results is that the
cell contributes to the transphosphorylating activity of the Phosphorylated RR1, IgG, and RR2 proteins were seen
in immunocomplex PK assays done in buffer containingRR1 proteins, possibly by virtue of the presence of factors
that activate the transphosphorylating potential. We ad- only Mn2/ ions (Figs. 10, 11, lanes 2–4). For both ICP6
and ICP10, relatively good levels of auto- and transphos-dressed this possibility by studying HSV-1 (MP)- and
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FIG. 12. (A) Protein profiles of [35S]methionine-labeled extract from
FIG. 10. Ion requirement of ICP6 PK. MAbG8 immunocomplex PK induced (lane 1) or not induced (lane 2) pJL-11 containing bacteria, 0–
assay of 10 hr HSV-1 (MP)-infected Vero cells with 50 mCi of [g-32P]ATP 30% (lane 3) or 40–55% (lane 4) ammonium sulfate fractions from
and different concentrations of Mn2/ and Mg 2/ ions. induced bacteria, and pp291a1 purified by heparin chromatography (lane
5). (B) MAb30 immunocomplex PK assay of extracts from uninduced
bacteria (lane 1), 40–55% (lane 2) or 0–30% (lane 3) ammonium sulfate
phorylation were first seen at 2 mM Mn2/ ions (Figs. 10, fractions of induced bacteria, purified pp291a1 in presence of 4 mg
exogeneously added CaM (lane 4) and purified pp291a1 alone (lane 5).11, lane 3; densitometric integration units 11,695 { 488
Molecular weight markers are shown.and 12,444 { 1,171 for ICP6 and RR2 at 2 mM Mn2/, as
compared to 3,042 { 112 and 4,963 { 541 at 0.5 mM
Mn2/). Both enzymes could use Mg2/ ions but with a
mM Mn2/, if the buffer also contained 1–10 mM Mg 2/lower efficiency. Thus, phosphorylated proteins were not
(Fig. 10, lanes 6, 10, 14; densitometric integration unitsseen in immunocomplex PK assays of extracts from HSV-  10,948 { 648 and 12,566 { 317 for ICP6 and RR2,1 (Fig. 10, lanes 5, 9)- or HSV-2 (Fig. 11, lanes 5, 9)-infected
respectively). The highest levels of phosphorylated pro-cells done in the absence of Mn2/ ions, suggesting that
teins were seen in presence of 10 mM of both Mn2/ andRR1 PK is Mn2/ dependent. Minimal activity was observed
Mg 2/ ions (Fig. 11, lane 16; densitometric integration unitswith Mg2/ ions alone, provided the concentration was  30,736 { and 8,598 { for ICP10 and RR2 at 10 mMrelatively high (10 mM ) (Figs. 10, 11, lanes 13). PK activity
Mn2//10 mM Mg 2/ ions as compared to 24,440 { 1,081was optimized by the presence of both Mn2/ and Mg 2/
and 9,623 { 680 at 10 mM Mn2//1 mM Mg 2/). Theseions as demonstrated by the observation that the levels
comparisons are valid since MAb G8 immunoblotting ofof phosphorylated proteins in HSV-1-infected cells as-
the PK immunoprecipitates in Figs. 10 and 11 indicate thatsayed at 0.5 mM Mn2/ were similar to those seen at 2
the RR1 levels in all assays did not differ by more than
2–4%.
Bacterially expressed ICP10 (pp29la1) has auto- and
transphosphorylating activity
If the ICP10 PK activity is due to a contaminating cellu-
lar kinase, ICP10 expressed in bacteria would be ex-
pected to be PK negative or to have a different PK activity
than that of ICP10 expressed in eukaryotic cells. To ad-
dress this question we studied the bacterial expression
vector pJL11 which expresses a truncated protein,
pp29la1 (Luo et al., 1991). We purified pp29la1 to apparent
homogeneity to exclude potentially contaminating, albeit
invisible, bacterial kinases. Extracts of induced pJL11-
containing bacteria were purified by 30% ammonium sul-
fate precipitation (Fig. 12A, lane 3) followed by heparin
chromatography (Fig. 12A, lane 5) and assayed for PK
activity in the presence of 2 mM Mn2//5 mM Mg 2/ ionsFIG. 11. Ion requirement of ICP10 PK. MAbG8 immunocomplex PK
with 10 mCi of [g-32P]ATP and 4 mg of calmodulin (CaM)assay of 10 hr HSV-2 (G)-infected Vero cells with 10 mCi of [g-32P]ATP
and different concentrations of Mn2/ and Mg 2/ ions. used as exogenous substrate (Chung et al., 1990; Luo et
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al., 1991). Autophosphorylating (Fig. 12B, lanes 3–5) and 1989, 1990; Luo et al., 1991, Luo and Aurelian, 1992), (ii)
kinase activity was retained by a bacterially expressedtransphosphorylating (Fig. 12B, lanes 3, 4) PK activity was
observed with pp29la1 partially purified by 30% ammo- ICP10 (pp29la1) and it is unlikely that similar contaminat-
ing kinases operate in eukaryotic and prokaryotic cellsnium sulfate fractionation (Fig. 12B, lane 3) or purified to
apparent homogeneity by heparin chromatography (Fig. (Luo et al., 1991), (iii) pp29la1 the bacterially expressed
ICP10 which lost PK catalytic sites for Ser/Thr-specificity12B, lanes 4, 5). PK activity was not seen in ammonium
sulfate fractions that did not contain pp29la1 (Fig. 12B, and Mg 2/-chelation [catalytic motifs VI and VII, respec-
tively, (Taylor et al., 1992)], did not respond to Mg 2/ ionslane 2), nor in unfractionated uninduced bacteria (Fig.
12B, lane 1). pp29la1 mutated in Lys176 (to Leu) had a 4- and was not Ser/Thr specific (Luo et al., 1991), (iv) ICP10
specifically bound the ATP analogue FSBA, (v) kinaseto 5-fold lower kinase activity than the wild type (data
not shown). These findings indicate that the bacterially activity was retained after electrophoresis on denaturing
gels and renaturation on nitrocellulose membranes (Luoexpressed pp29la1 has auto- and transphosphorylating
activity. and Aurelian, 1992), and (vi) kinase activity was lost by
a mutant (pJHL15) which retains all known target sites
for cellular kinases (Luo and Aurelian, 1992; Smith et al.,DISCUSSION
1994; Hunter et al., 1995). Recent studies using insertion
mutagenesis also concluded that the ICP6 PK activity isThe PK domain of the HSV RR1 proteins is uniquely
present in HSV-1 and HSV-2 and it functions indepen- intrinsic (Cooper et al., 1995).
By logic we cannot exclude the existence of a contami-dently of the RR domain. Although its exact role is still
unclear, it is generally accepted that the PK activity plays nating cellular kinase responsible for the RR1 PK activity
because it can always be argued that the contaminant isa key role in virus pathogenesis. Since RR1 phosphoryla-
tion is not required for its function in RR activity, the invisible. However, in our studies, there is no background
activity in immunoprecipitates from: (i) mock-infected orassumption that the PK is involved in virus pathogenesis
presumes that this is due to its ability to transphosphory- untransfected cells, (ii) transfected or infected cells precip-
itated with NMS, and (iii) purified fractions from uninducedlate other viral and/or cellular proteins (Wymer et al.,
1989; Chung et al., 1989; Conner et al., 1992a, 1994; bacteria. If present, the contaminating activity in this study
is less than 0.1% of the specific activity of the wild-typeDesai et al., 1993; Ramakrishnan et al., 1994).
Although a wealth of evidence indicates that the RR1 ICP10 since the TM deleted mutant enzyme was some-
times detectable within this range (data not shown). InPK activity is intrinsic (Chung et al., 1989, 1990; Luo et
al., 1991; Paradis et al., 1991; Ali et al., 1991, 1992; Luo addition, ICP10 PK has different properties than CKII (does
not require monovalent cations and is not inhibited by zincand Aurelian, 1992; Conner et al., 1992a; Cooper et al.,
1995), our studies were prompted by recent conflicting sulfate), CKII was not observed in immunoblots of the PK
positive or negative immunoprecipitates (data not shown),results about its transphosphorylating potential (Ali,
1995) and the suggestion that its PK activity is due to and mutants pJHL15 and pJHL4 are PK defective although
they retain all known target sites for CKII and other cellularcontamination by CKII (Langelier, personal communica-
tion). We find that unlike CKII, which requires monovalent PKs. The PK defect of pJHL15 is not due to the loss of the
binding site (as opposed to target sites) for the putativecations and is inhibited by zinc sulfate (Gatica et al.,
1993), ICP10 PK activity is optimal in the absence of KCl contaminating kinase since the ICP10 sequences deleted
from pJHL15 are a functional TM segment (Hunter et al.,and is not inhibited by ZnSO4 . Additionally: (i) the RR1
PK activity is optimal with Mn2/ rather than Mg 2/ ions 1995) and it is unlikely that the single amino acid mutated
in pJHL4 is responsible for binding the putative contami-while CKII activity is optimal with Mg 2/ rather than Mn2/
(Gatica et al., 1993) and (ii) ICP10 PK activity is abro- nating kinase.
How does ICP10 mutation cause loss of PK activity?gated/impaired by deletion of the TM segment or muta-
tion of Lys176 although the mutants retain all known target Presumably pJHL15 is PK negative because TM deletion
causes perturbation of the configuration of the activesites for cellular kinases (including CKII). The Lys176 mu-
tant is significantly impaired in its ability to bind the ATP site, and pJHL9 is PK negative because it lost all PK
catalytic motifs and cannot bind ATP. Deletion of aminoanalogue FSBA, and the ICP6 and ICP10 PK activities
have different ATP requirements. These observations in- acids downstream of the catalytic motifs (411–1144) did
not abrogate ICP10 PK activity (Chung et al., 1989). pJHL4dicate that RR1 PK activity is intrinsic, and it has both
auto- and transphosphorylating potential. Presumably, is likely to be PK defective because the mutated Lys
residue is involved in catalysis, substrate recognition, orprevious conflicting results are due, at least in part, to
the use of different RR1 preparations and experimental structural integrity of the active site. Lys176 is in the puta-
tive ATP binding site (Taylor et al., 1992). Its mutationconditions (Table 1).
Previous reports concluded that the ICP10 PK activity causes a significant reduction in PK activity and FSBA
binding relative to the wild-type ICP10, suggesting thatis intrinsic because: (i) contaminating kinases were not
observed in ICP10 PK immunocomplexes (Chung et al., Lys176 is involved in ATP binding. The somewhat higher
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TABLE 1
RR1 PK Assays and Their Conditions
RR1 Mg2/ Mn2/ NaCl [g-32P]ATP Basic
(ICP) (mM) (mM) (mM) (mCi) protein Cells Reference
10/6 5 — — 10 — HEp-2, Vero Chung et al., 1989
10 0.1–5 2 — 10 PolyLys HEp-2 Chung et al., 1990
10 10 2 — 10 — pure protein Luo et al., 1991
6 2.5 0.5 300 100 — pure protein Paradis et al., 1991
10 5 — — 50 — Cos-7, Rat-2 Ali et al., 1991
10 1–10 0.5–5 — 10 — 293 Luo and Aurelian, 1992
6 — 0.5 250 10 Protamine pure protein Conner et al., 1992
10 5 — — 50 — Cos-7 Ali et al., 1992
6/10 5 — — 10 — CV-1 Ali, 1995
6/10 — 1 250 30 Protamine pure protein Cooper et al., 1995
Note. Results represent summary of data from listed references.
enzymatic impairment observed by us as compared to studied bacterially expressed RR1 proteins found that
they are transphosphorylation defective. Careful assess-Luo and Aurelian (1992) presumably reflects our use of
stably transfected cells and the careful equilibration of ment of the data of Conner et al. (1992) (Fig. 5B, lane 3)
indicates that the FPLC fraction which has the bulk ofprotein levels in PK assays. Similar results were also
obtained with a Lys176 mutant of the bacterial expression the trans- but not autophosphorylating activity, contains
residual ICP6, possibly suggesting that the ICP6 trans-vector pp29la1 (data not shown), further supporting the
interpretation that the kinase activity is intrinsic to ICP10. phosphorylating potential is superior, at least under the
studied assay conditions. We find that the levels of phos-However, mutation of Lys176 does not abrogate PK activity
and FSBA binding, suggesting that other Lys residues phorylated RR2 and IgG are sometimes higher than those
of phosphorylated ICP6. However, the differences arecould also bind ATP. This is not novel, having been pre-
viously reported for yeast cAMP kinase in which mutation small and not totally reproducible. Alternatively, the fail-
ure of Conner and colleagues to detect transphosphory-of the invariant Lys was insufficient to abrogate PK activ-
ity and mutation of two other nonconserved Lys residues lating activity reflects different properties of the proteins
expressed in prokaryotic as compared to eukaryoticcaused a similar reduction of PK activity. The findings
were interpreted to indicate that the protein structure cells. The internal milieu of the eukaryotic cell could stim-
ulate transphosphorylation, or the bacterial milieu couldallows either one of these Lys residues to bind ATP
(Gibbs and Zoller, 1991). We find that mutation of Lys259 cause a different quartenary structure or minor mutations
(detectable only by protein sequencing) which are incom-causes a 8- to 10-fold reduction in ICP10 PK activity and
FSBA binding and these are abrogated by mutation of patible with PK activity. According to this interpretation
the purified bacterially expressed pp29la1 has PK activityboth Lys176 and Lys259 (Nelson et al., in preparation), con-
firming that ICP10 PK activity is intrinsic. The finding that because the ICP10 region that is lost by pp29la1 (amino
acids 284–1141) contains interfering sequences in bac-ICP6 and ICP10 PK activities differ in their ATP require-
ments also support the interpretation that the RR1 PK terial cells. Indeed, histone is a substrate for ICP10 PK
in eukaryotic cells, but it inhibits the PK activity of pp291a1activities are intrinsic and suggest that the difference
may be due to: (i) the failure of ICP6 to conserve the in bacterial cells (Luo et al., 1991).
Our observations are difficult to reconcile with the find-invariant Lys (Lys176 in ICP10) and/or (ii) the different
location of the ATP binding sites. Indeed, the ICP6 ATP ings of Ali (1995), who used extracts of virus-infected
cells and concluded that the RR1 PK activity is transphos-binding site is within amino acids 305–575 outside of
the PK catalytic domain (Cooper et al., 1995). phorylation defective using histone as substrate. Ali’s
finding is particularly confusing since PK assays wereSignificantly, loss of auto- and transphosphorylating
activity was also seen in cells infected with the done at suboptimal conditions, at which we and others
(Chung et al., 1989) did not find ICP6 PK activity, andICP10DPK virus that is deleted in the ICP10 conserved
PK catalytic motifs. This indicates that PK activity is not previous studies from the same laboratory reported both
auto- and transphosphorylating activities in eukaryoticdue to other viral PKs or to cellular PKs induced by virus
infection. Relevant is also the detection of ICP10 PK activ- cells transfected with ICP10 expression vectors (Ali et
al., 1991, 1992). Given the paucity of information on theity at 4 hr p.i. (unpublished; Chung et al., 1989) while viral
PKs (UL13 and US3) are expressed late (⁄13 hr) in the identity of the phosphorylated proteins observed by Ali
(1995), the possibility cannot be excluded that they repre-virus growth cycle (Purves et al., 1992, 1993).
Conner et al. (1992a) and Cooper et al. (1995) who sent transphosphorylation substrates or RR1 breakdown
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subunit of herpes simplex virus type 2. Proc. Natl. Acad. Sci. USAproducts that were transphosphorylated by ICP10/ICP6
88, 8257–8261.PK. Our findings point to the contribution of the MAb used
Ali, M. A., Prakash, S. S., and Jariwalla, R. J. (1992). Localization of thein the PK assay toward detectable transphosphorylation. antigenic sites and intrinsic protein kinase domain within a 300
Indeed, any protein that is coprecipitated with RR1, be it amino acid segment of the ribonucleotide reductase large subunit
as a complex or because it shares an epitope recognized from herpes simplex virus type 2. Virology 187, 360–367.
Anderson, K. P., Frink, R. J., Devi, G. B., Gaylord, B. H., and Wagner,by the MAb, could serve as a phosphorylation substrate.
E. K. (1981). Detailed characterization of the mRNA mapping in theIgG is an obvious candidate and it is an established
HindIII fragment K region of the herpes simplex virus type 1 genome.substrate for many kinases (Moelling et al., 1984). Pre-
J. Virol. 37, 1011–1027.
sumably, a high affinity IgG is less likely to be detected Averett, D. R., Lubbers, C., Elion, G. B., and Spector, T. (1983). Ribonucle-
as its levels in the precipitates are lower than those of otide reductase induced by herpes simplex virus type 1. Character-
ization of a distinct enzyme. J. Biol. Chem. 258, 9831–9838.a lower affinity IgG. This is exemplified by our observa-
Aurelian, L., Terzano, P., Smith, C. C., Chung, T. C., Shamsuddin, A.,tion that IgG is not phosphorylated in MAb30 immunopre-
Costa, S., and Orlandi, C. (1989). Amino terminal epitope of herpescipitates while it is generally detected in MAbG8 assays.
simplex virus type 2 ICP10 protein as a molecular diagnostic marker
A phosphorylated 180-kDa protein was observed in for cervical intraepithelial neoplasia. In ‘‘Molecular Diagnostics of
MAb99 PK assays and phosphorylated proteins were de- Human Cancer. Cancer Cells,’’ Vol. 7, pp. 187–191. Cold Spring Har-
bor Laboratory, Cold Spring Harbor, NY.tected in MAbG9 assays in the absence of ICP10 PK
Bacchetti, S., Evelegh, M. J., Muirhead, M., Satori, C. S., and Huszar,activity. The difference between our findings and those
D. (1984). Immunological characterization of herpes simplex virusof Ali (1995) may reflect the use of different MAbs, since
type 1 and 2 polypeptide(s) involved in viral ribonucleotide reductaseAli used MAb 51S that recognizes an epitope (Ali et al., activity. J. Virol. 49, 591–593.
1992) located within 20 amino acids conserved in ICP10/ Bacchetti, S., Evelegh, M., and Muirhead, B. (1986). Identification and
ICP6 which are involved in antibody-mediated inhibition separation of the two subunits of the herpes simplex virus ribonucle-
otide reductase. J. Virol. 57, 1177–1181.of ICP10 PK activity (Chung et al., 1990).
Chung, T. D., Wymer, J. P., Smith, C. C., Kulka, M., and Aurelian, L.Using higher protein concentrations (⁄2.5 mg) in im-
(1989). Protein kinase activity associated with the large subunit ofmunoprecipitation/immunoblotting assays, we confirmed
herpes simplex virus type 2 ribonucleotide reductase (ICP10). J. Virol.
the findings of Smith et al. (1994) and Hunter et al. (1995) 63, 3389–3398.
that ICP10 binds signaling proteins ras-GAP and Grb2- Chung, T. D., Wymer, J. P., Kulka, M., Smith, C. C., and Aurelian, L.
(1990). Myristylation and polylysine-mediated activation of the proteinhSos (unpublished), and we are cognizant of the appar-
kinase domain of the large subunit of herpes simplex virus type 2ent role of ICP10 proline-rich domains (SH3-binding) in
ribonucleotide reductase (ICP10). Virology 179, 168–178.this interaction (Santana-Verano, personal communica-
Chung, T. D., Luo, J. H., Wymer, J. P., Smith, C. C., and Aurelian, L.tion). However, viruses do not tend to carry superfluous (1991). Leucine repeats in the large subunit of herpes simplex virus
genetic information that does not confer a selective type 2 ribonucleotide reductase (RR; ICP10) are involved in RR activity
growth advantage, and it is improbable that the RR1 PK and subunit complex formation. J. Gen. Virol. 72, 1139–1144.
Cohen, E. A., Charron, J., Perret, J., and Langelier, Y. (1985). Herpesdomains were conserved only for their ability to interact
simplex virus ribonucleotide reductase induced in infected BHK 21/with other proteins. A much more likely interpretation is
C13 cells: biochemical evidence for the existence of two non-identi-that PK activity is an intrinsic property of ICP10/ICP6,
cal subunits H1 and H2. J. Gen. Virol. 66, 733–745.
serving to activate cellular and/or viral proteins that aug- Conner, J., Cooper, J., Furlong, J., and Clements, J. B. (1992a). An auto-
ment the efficiency of virus replication and/or its ability phosphorylating but not transphosphorylating activity is associated
to establish or reactivate from a latent state by virtue of with the unique N terminus of the large herpes simplex virus type 1
ribonucleotide reductase large subunit. J. Virol. 66, 7511–7516.its transphosphorylating potential. Further studies of the
Conner, J., Macfarlane, J., Lankinen, H., and Marsden, H. (1992b). TheICP10DPK virus will be needed in order to evaluate this
unique N terminus of the herpes simplex virus type 1 large subunitpossibility.
is not required for ribonucleotide reductase activity. J. Gen. Virol. 73,
103–112.
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